Trial Search Results

Autologous Regenerative Technology (ART) For Wound Healing

The purpose of the study is to provide a more effective method of harvesting skin with minimal or no pain, heal more rapidly with little scarring in an outpatient setting with the use of only local anesthesia.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Device: Autologous Regenerative Technology (ART)




Inclusion Criteria:

   - Any age ranging 18-90, any gender or ethnic background is a candidate.

   - Subjects with chronic wounds that have been present for at least 4 weeks

Exclusion Criteria:

   - Pregnant women.

   - Adults unable to consent.

   - Prisoners.

   - Subjects requiring concurrent systemic antimicrobials during the study period for any

   - Subjects with leg lesions and clinically significant and unreconstructed peripheral
   arterial disease.

   - Subjects who are receiving immunosuppressive agents, radiation therapy, or cytotoxic

   - Subjects who require treatment for a primary or metastatic malignancy (other than
   squamous or basal cell carcinoma of the skin).

   - Subjects with other conditions considered by the investigator to be reasons for
   disqualification that may jeopardize subject safety or interfere with the objectives
   of the trial (e.g., acute illness or exacerbation of chronic illness, lack of
   motivation, history of poor compliance).

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Shannon Meyer
Not Recruiting